Renovos Biologics

Renovos Biologics is a private, preclinical-stage biotech company commercializing world-class research from the University of Southampton. Its core asset is the RENOVITE® platform, a synthetic nanoclay gel designed as an injectable scaffold to localize and retain biologics and cells for targeted tissue regeneration, primarily in orthopedic applications. The company is pre-revenue and appears to be seeking investment and partnerships to advance its platform and pipeline programs. Leadership combines deep academic expertise in skeletal stem cells and biomaterials with entrepreneurial business development.

RENOVITE®: A proprietary synthetic nanoclay gel that forms an injectable scaffold for the precise localization and retention of therapeutic agents (cells, biologics) to template tissue formation.

Renovos competes in the broad orthobiologics and regenerative medicine space, which includes large players like Medtronic, Stryker, and Zimmer Biomet, as well as numerous startups developing hydrogel, polymer, and extracellular matrix scaffolds. Its key differentiator is the use of synthetic nanoclay for precise therapeutic retention and dosing control.